Name | Value |
---|---|
Revenues | 2,367.0K |
Cost of Revenue | 711.0K |
Gross Profit | 1,656.0K |
Operating Expense | 3,188.0K |
Operating I/L | -1,532.0K |
Other Income/Expense | 3,890.0K |
Interest Income | 0.0K |
Pretax | 2,358.0K |
Income Tax Expense | 0.0K |
Net Income/Loss | 2,358.0K |
Nuwellis, Inc. is a medical device company specializing in developing, manufacturing, and selling medical devices for ultrafiltration therapy. The company's flagship products, the Aquadex FlexFlow and Aquadex SmartFlow systems, are designed for treating patients with fluid overload who have not responded to diuretics. The Aquadex FlexFlow system comprises a console, disposable blood set, and catheter. Nuwellis, Inc. generates revenue by selling its products directly to hospitals and clinics in the United States, as well as through independent specialty distributors in various international markets.